Transpact Enter. (542765)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

Let me start with what I know: this is a medical equipment company with a market capitalisation of just ₹13 crore and a share price of ₹325. The latest quarter shows sales of ₹0 crore and net profit of ₹0 crore. I cannot value a business that does not currently show revenue. Benjamin Graham said that ‘the investor’s chief problem—and even his worst enemy—is likely to be himself.’ My defence is discipline: I need a business that earns more than its cost of capital. Here return on equity is -44.07% and return on capital employed is 0.00%. That is not a wealth-creating machine; that is capital destruction. The reported profit growth of 200% and a PEG ratio of 0.34 look exciting in a broker’s note, but a 200% improvement from a barely-above-zero base is meaningless to me. The price-to-earnings ratio is 67.60, yet the latest quarter’s net profit is ₹0 crore. With book value of only ₹9.47 and price-to-book of 34.32, I am paying 34 times for assets, with no earnings to justify that premium. No dividend arrives while I wait. I also see 'N/A' for promoter holding and debt/equity. As an outside minority shareholder, I need honest and complete reporting; if I cannot see who owns the business and how much debt it has, I cannot trust my capital to it. The stock has moved from ₹119.55 to ₹325.00, but price movement is not a moat. A great business, in Graham’s language, is one where the owners can depend on earnings power. Here there is no sales growth, no revenue, and no recorded ROCE. If the company is truly at a turning point, the next few financial statements must show actual sales and positive operating profits. Until then, I will sit on my hands. In investing, a small company with zero revenue can be a lottery ticket, not an investment.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer